Stock screener

DNA

Conviction 34HealthcareScan · Mon, Aug 10, 2026
DNA$7.65-4.02%
ResistanceSupportVol 14Insider sell
63 bars
Vol MA14 1.06M
May 11May 28Jun 16Jul 6Jul 23Aug 10
WSB mentions · 24h changelatest +100.00%· 2 mentions
May 11May 28Jun 16Jul 6Jul 23Aug 10
Ginkgo Bioworks Holdings, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.ginkgobioworks.com ↗
Price7.65
Change-4.02%
Gap-2.26%
Rel volume2.66×
Avg volume1.01M
Avg $ vol8.27M
SMA 208.18
SMA 508.73
SMA 2008.68
Price vs 50-12.34%
Price vs 200-11.87%
MA stackmixed
50/200 crossgolden · 3d
Supertrenddown · 9.88
RSI (14)41
MACD hist0.02
MACD crossbull · 5d
Stoch %K / %D18 / 34
ADX (14)20
+DI / −DI21 / 29
RSI divergence—
MACD divergence—
ATR %+8.52%
ADR %6.59%
52w high16.14
52w low5.48
From 52w high-52.60%
Above 52w low+39.60%
New 52w highNo
SqueezeOff
Bollinger width30.48%
%B0.29
Donchian pos17.70%
Donchian high9.65
Donchian low7.22
AVWAP (52w high)9.12
vs AVWAP high-16.08%
AVWAP (52w low)8.53
vs AVWAP low-10.37%
OBV trendDown
Chaikin MF (20)-0.15
Today vs 20d2.66×
Avg vol (14d)1.06M
Avg vol (20d)1.01M
Avg $ vol (20d)8.27M
Market cap487.39M
RS 3m (vs SPY)-28.47%
RS 6m (vs SPY)-18.32%
RS line new highNo
Trend template1/8
Technical rank13.2
1 week-14.43%
1 month-15.84%
3 months-14.33%
6 months-24.26%
1 year-43.16%
YTD-12.07%
P/E-1.56
P/B1.16
P/S2.86
P/FCF-2.73
EPS-5.64
Div yield—
ROE-74.42%
ROA-31.59%
Debt/Eq—
Current4.57
EV/EBITDA-1.57
Gross margin—
Net margin-183.81%
Rev growth-25.06%
EPS growth42.83%
Price target9.00
Target upside17.65%
Analyst ratingSell
Institutional66.81%
Ent. value402.85M
Revenue20.16M
Net income-46.71M
Gross profit—
Free cash flow-178.72M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNYSE
Shares out53.36M
Employees485
ListedMon, Apr 19, 2021
Free float40.26M
Float %80.6%
Short interest5.21M
Days to cover5.0d
Short volume49.9%
Squeeze score72 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.86
Last surprise—
Setup gradeD
Conviction34 / 100
Pattern quality—
Tech rank13.2 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance10.47
Support7.33
Days since event—
Candle confirm—
News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 47 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

  1. Broke out
    May 29
    1 scan
  2. Setting up
    Jun 24 – Jul 1
    5 scans

Congress activity

Disclosed STOCK Act trades in DNA

All disclosures →
No recent disclosed trades by Congress in DNA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in DNA · 4 buys · 6 sells

InsiderSideShares
Coen Steven P.
See remarks · Class A Common Stock · 2026-05-22
Sell307
Coen Steven P.
See remarks · Restricted Stock Units · 2026-05-21
Exercise587
Coen Steven P.
See remarks · Restricted Stock Units · 2026-05-21
Exercise156
Coen Steven P.
See remarks · Class A Common Stock · 2026-05-21
Exercise587
Coen Steven P.
See remarks · Class A Common Stock · 2026-05-21
Exercise156
Coen Steven P.
See remarks · Class A Common Stock · 2026-04-17
Sell324
Coen Steven P.
See remarks · Restricted Stock Units · 2026-04-16
Exercise156
Coen Steven P.
See remarks · Class A Common Stock · 2026-04-16
Exercise587
Coen Steven P.
See remarks · Class A Common Stock · 2026-04-16
Exercise156
Coen Steven P.
See remarks · Restricted Stock Units · 2026-04-16
Exercise587

SEC filings

EDGAR filings in DNA · 7 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.